-+ 0.00%
-+ 0.00%
-+ 0.00%

UK'S MHRA: TRIHEPTANOIN (DOJOLVI) APPROVED TO TREAT ADULTS AND CHILDREN WITH A GROUP OF RARE INHERITED DISORDERS

Reuters·10/30/2026 14:57:39

Please log in to view news